A detailed history of Nisa Investment Advisors, LLC transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 3,529 shares of RVMD stock, worth $159,369. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,529
Previous 3,378 4.47%
Holding current value
$159,369
Previous $131,000 21.37%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$36.92 - $47.94 $5,574 - $7,238
151 Added 4.47%
3,529 $159,000
Q2 2024

Jul 19, 2024

BUY
$30.14 - $40.68 $9,644 - $13,017
320 Added 10.46%
3,378 $131,000
Q1 2024

May 01, 2024

BUY
$26.56 - $33.55 $16,653 - $21,035
627 Added 25.79%
3,058 $98,000
Q4 2023

Jan 25, 2024

SELL
$18.35 - $34.12 $13,230 - $24,600
-721 Reduced 22.87%
2,431 $69,000
Q2 2023

Aug 11, 2023

BUY
$20.28 - $27.0 $19,103 - $25,434
942 Added 42.62%
3,152 $84,000
Q3 2022

Nov 07, 2022

BUY
$17.46 - $26.0 $1,047 - $1,560
60 Added 2.79%
2,210 $45,000
Q2 2022

Aug 03, 2022

BUY
$14.54 - $27.17 $10,905 - $20,377
750 Added 53.57%
2,150 $42,000
Q1 2022

Apr 29, 2022

SELL
$17.31 - $26.4 $16,963 - $25,872
-980 Reduced 41.18%
1,400 $36,000
Q4 2021

Feb 03, 2022

SELL
$24.35 - $33.7 $2,191 - $3,033
-90 Reduced 3.64%
2,380 $51,000
Q2 2021

Aug 06, 2021

BUY
$29.0 - $47.44 $28,130 - $46,016
970 Added 64.67%
2,470 $78,000
Q4 2020

Jan 25, 2021

SELL
$30.19 - $45.49 $9,932 - $14,966
-329 Reduced 17.99%
1,500 $59,000
Q3 2020

Oct 20, 2020

BUY
$22.61 - $34.8 $41,353 - $63,649
1,829 New
1,829 $64,000

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.96B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.